WELCOME to epgonline.org

Access trusted, independent sources of clinical content for the United Kingdom as well as other regions. Registration is quick and simple, providing you with unlimited access to all content and features.
 

Latest News

Added 1 day ago Drug news

Phase III trial of Inflectra (infliximab CT-P13) meets endpoint in Crohn’s disease- Pfizer and Celltrion Healthcare

Data announced by Pfizer and Celltrion Healthcare showed that for patients with moderate-to-severe Crohn’s disease (CD), treatment with Inflectra (infliximab...

Added 1 day ago Drug news

Tivantinib fails to meet endpoint in METIV-HCC Phase III trial for hepatocellular carcinoma.- ArQule Inc. + Daiichi Sankyo

ArQule, Inc.and Daiichi Sankyo announced that the METIV-HCC phase III study of tivantinib in hepatocellular carcinoma (HCC) did not meet...

Added 2 days ago Drug news

Phase III ADMIRE-CD clinical trial of Cx 601 (adipose-derived stem cells) shows long term remission in Crohn's disease- Takeda/TiGenix

Takeda Pharmaceutical Company and TiGenix announced new data from the Phase III ADMIRE-CD clinical trial, which indicated that Cx 601,...

View all news articles

 

Latest Journal Abstracts

Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis.

Interleukin-17A (IL-17A) is elaborated by the T helper 17 (T(H)17) subset of T(H) cells and exhibits potent proinflammatory properties in animal models of autoimmunity, including collagen-induced arthritis, experimental ...

Added 8 hours ago

Anti-interleukin-17 monoclonal antibody ixekizumab in psoriasis.

The articles by Papp and colleagues and Leonardi and colleagues (both in the March 29 issue) attest to the growing interest in the therapeutic potential of agents such as ixekizumab and...

Added 8 hours ago

Treatment with the interleukin-17a-blocking antibody secukinumab does not interfere with the efficacy of influenza and meningococcal vaccinations in healthy subjects: Results of an open-label, parallel-group, randomised single-center study

Our objective was to evaluate the efficacy of influenza and meningococcal vaccinations in healthy subjects exposed to the anti-interleukin-17A (IL-17A) monoclonal antibody (MAb) secukinumab.

Added 8 hours ago

View all journal articles

Latest Guidelines

Adalimumab for the treatment of adults with psoriasis

The severity of a person's psoriasis before and during treatment should be assessed by considering the redness, thickness and scaliness of the plaques, the area of the body involved, and how the condition...

Added 4 days ago

British Association of Dermatologists’ guidelines for biologic interventions for psoriasis 2009

Psoriasis is a common, chronic inflammatory skin disease which typically follows a relapsing and remitting course, and is associated with joint disease in approximately 25% of patients.

Added 4 days ago

Clinical practice guideline for an integrated approach to comorbidity in patients with psoriasis

To provide the dermatologist a guide focuses specifically on the diagnosis and management of the diseases most often found in patients with psoriasis.

Added 4 days ago

View all guidelines